BIOSENTINEL, LLC

Company Information

Company Name
BIOSENTINEL, LLC
Address
510 Charmany Drive
Suite 259
Madison, WI, -
Phone
n/a
URL
n/a
DUNS
199748000
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$949,846.00
3
SBIR Phase II
$1,842,045.00
2
Chart code to be here

Award List

  1. SBIR Phase I:De novo assays for detection of the proteolytic activity in botulinum neurotoxin-based pharmaceuticals

    Amount: $150,000.00

    This Small Business Innovation Research (SBIR) Phase I project proposes to develop a universal, in vitro assay for determining the enzymatic activity of botulinum neurotoxin (BoNT)-based pharmaceutica ...

    SBIR Phase I 2010 National Science Foundation
  2. A Cell-based Assay for Botulinum Neurotoxin Detection and Development

    Amount: $587,536.00

    DESCRIPTION (provided by applicant): Botulinum neurotoxins (BoNT) are the most toxic substances known to humans causing respiratory failure upon poisoning. BoNT's lethality and ease of production has ...

    SBIR Phase I 2009 Department of Health and Human Services
  3. A Cell-based Assay for Botulinum Neurotoxin Detection and Development

    Amount: $1,425,680.00

    DESCRIPTION (provided by applicant): Botulinum neurotoxins (BoNTs) are the most toxic substances known to humans, causing respiratory failure. Because of their lethality and ease of production, the De ...

    SBIR Phase II 2011 Department of Health and Human Services
  4. Validation of a cell-based assay for BoNT/A detection against the mouse bioassay

    Amount: $212,310.00

    DESCRIPTION (provided by applicant): Botulinum neurotoxins (BoNT) are the most toxic substances known to humans, causing respiratory failure upon intoxication. Despite their lethality, BoNTs have clin ...

    SBIR Phase I 2011 Department of Health and Human Services
  5. SBIR Phase II: De novo assays for detection of the proteolytic activity in botulinum neurotoxin-based pharmaceuticals

    Amount: $416,365.00

    This Small Business Innovation Research (SBIR) Phase II project proposes to complete development of a universal, in vitro assay for determining the enzymatic activity of botulinum neurotoxin (BoNT)-ba ...

    SBIR Phase II 2012 National Science Foundation

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government